Top-Rated Stocks NASDAQ:CYTK Cytokinetics - CYTK Insider Trading & Ownership Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytokinetics, Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. $35.19 +0.98 (+2.86%) (As of 03/31/2023 12:00 AM ET) Add Compare Share Share Today's Range$34.70▼$36.6650-Day Range$33.36▼$45.7152-Week Range$32.96▼$55.80Volume3.04 million shsAverage Volume1.15 million shsMarket Capitalization$3.36 billionP/E RatioN/ADividend YieldN/APrice Target$57.21 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Cytokinetics (NASDAQ:CYTK) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.00%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$16.18 M CYTK Insider Buying and Selling by Quarter Get CYTK Insider Trade Alerts Want to know when executives and insiders are buying or selling Cytokinetics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Cytokinetics Insider Trades History Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails3/28/2023Robert I BlumCEOSell12,500$35.05$438,125.00441,058 3/15/2023Robert I BlumCEOSell12,500$37.26$465,750.00441,058 3/9/2023Fady Ibraham MalikEVPSell4,000$39.10$156,400.00171,183 3/6/2023Robert I BlumCEOSell12,500$39.94$499,250.00370,458 2/21/2023Robert WongCAOSell2,234$45.21$100,999.1424,789 2/9/2023Fady Ibraham MalikEVPSell4,000$43.73$174,920.00152,589 2/3/2023Robert WongCAOSell3,004$45.00$135,180.0027,533 1/17/2023Robert I BlumCEOSell10,000$42.43$424,300.00406,412 1/12/2023Fady Ibraham MalikEVPSell4,000$40.47$161,880.00156,589 1/4/2023Robert I BlumCEOSell10,000$44.24$442,400.00406,412 12/5/2022Robert I BlumCEOSell10,000$39.30$393,000.00406,412 11/14/2022Robert WongCAOSell2,100$40.68$85,428.0030,537 11/10/2022Fady Ibraham MalikEVPSell4,000$38.04$152,160.00164,346 11/2/2022Robert I BlumCEOSell10,000$42.17$421,700.00406,089 10/19/2022Robert I BlumCEOSell10,000$47.86$478,600.00406,089 10/13/2022Fady Ibraham MalikEVPSell21,513$47.28$1,017,134.64168,346 10/3/2022Robert I BlumCEOSell10,000$50.40$504,000.00406,089 9/19/2022Robert I BlumCEOSell10,000$51.42$514,200.00406,089 9/12/2022John T HendersonDirectorSell21,759$54.94$1,195,439.4624,049 9/8/2022Fady Ibraham MalikEVPSell21,500$51.88$1,115,420.00168,346 9/7/2022Robert I BlumCEOSell10,000$49.11$491,100.00406,089 8/17/2022Robert I BlumCEOSell10,000$50.11$501,100.00409,124 8/1/2022Robert I BlumCEOSell10,000$41.26$412,600.00409,124 7/18/2022Robert I BlumCEOSell10,000$40.49$404,900.00409,472 7/14/2022Fady Ibraham MalikEVPSell21,500$43.43$933,745.00168,346 7/6/2022Robert I BlumCEOSell10,000$44.38$443,800.00409,472 6/6/2022Robert I BlumCEOSell10,000$41.23$412,300.00409,472 5/16/2022Robert I BlumCEOSell10,000$43.11$431,100.00409,124 5/12/2022Fady Ibraham MalikEVPSell13,987$37.54$525,071.98168,084 5/4/2022Robert I BlumCEOSell10,000$39.43$394,300.00409,124 4/20/2022Robert I BlumCEOSell10,000$37.89$378,900.00409,124 4/7/2022Fady Ibraham MalikEVPSell23,148$42.58$985,641.84168,084 4/4/2022Ching JawCFOSell15,000$40.00$600,000.0067,109 4/4/2022Robert I BlumCEOSell10,000$38.78$387,800.00409,124 (Data available from 1/1/2013 forward) CYTK Insider Trading Activity - Frequently Asked Questions Who is on Cytokinetics's Insider Roster? The list of insiders at Cytokinetics includes B Lynne Parshall, Bvf Partners L P/Il, Ching Jaw, David Cragg, Edward M Md Kaye, Fady Ibraham Malik, John T Henderson, L Patrick Gage, Mark A Schlossberg, Robert I Blum, Robert Wong, Sandford D Smith, Santo J Costa, and Wendall Wierenga. Learn more on insiders at CYTK. What percentage of Cytokinetics stock is owned by insiders? 5.00% of Cytokinetics stock is owned by insiders. Learn more on CYTK's insider holdings. Which Cytokinetics insiders have been selling company stock? The following insiders have sold CYTK shares in the last 24 months: B Lynne Parshall ($369,162.36), Ching Jaw ($2,445,096.51), David Cragg ($3,419,469.75), Edward M Md Kaye ($675,000.00), Fady Ibraham Malik ($7,683,243.44), John T Henderson ($1,535,559.46), L Patrick Gage ($1,093,922.44), Mark A Schlossberg ($1,569,705.62), Robert I Blum ($10,690,625.00), Robert Wong ($321,607.14), Sandford D Smith ($1,812,192.91), Santo J Costa ($373,500.00), and Wendall Wierenga ($184,845.42). How much insider selling is happening at Cytokinetics? Insiders have sold a total of 892,143 Cytokinetics shares in the last 24 months for a total of $34,152,490.35 sold. This page (NASDAQ:CYTK) was last updated on 4/2/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.